stockrowAlnylam Pharmaceuticals, Inc. (ALNY) vs Incyte Corporation (INCY)
- Alnylam Pharmaceuticals, Inc. ALNY 156.64 −0.01%
- Incyte Corporation INCY 118.21 +0.17%
Alnylam Pharmaceuticals, Inc. and Incyte Corporation are both Biotechnology companies. Incyte Corporation is the larger, with a market value of $24.1B against $21.0B — 1.1× the size. Alnylam Pharmaceuticals, Inc. trades at the lower P/E: 7.9× against 56.3×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 56.2% against 24.9%. Alnylam Pharmaceuticals, Inc. has the higher net margin (52.9% vs 6.71%) and the higher return on invested capital (59.4% vs 21.6%). Across the 21 metrics below, Alnylam Pharmaceuticals, Inc. leads on 14 and Incyte Corporation on 7.
Valuation
Profitability
| Metric | ALNY | INCY | Biotechnology median |
|---|---|---|---|
| Gross margin | 77.28% | 92.69% | 65.16% |
| Operating margin | 19.50% | 10.42% | 0.00% |
| Net margin | 52.85% | 6.71% | 0.00% |
| Free cash flow margin | 16.08% | 11.31% | 0.00% |
| Return on equity | 138.07% | 7.84% | (50.12%) |
| Return on assets | 41.25% | 5.92% | (45.60%) |
| Return on invested capital | 59.37% | 21.56% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack